Loading market dashboard

Estimates, scoring, valuation assumptions, and peer comparison in one research surface.
Antisense Therapeutics Limited · Forecast overview
Bars show expected revenue while the line tracks expected EPS.
| Period | Revenue avg | Revenue range | EBITDA | EPS avg | Analysts |
|---|---|---|---|---|---|
| Jun 2027 | $11.22M | $11.22M - $11.22M | -$11.22M | -$0.013 | 1 |
| Jun 2026 | $964.3K | $964.3K - $964.3K | -$964.3K | -$0.022 | 1 |
| Jun 2025 | $2.55M | $2.55M - $2.55M | -$2.55M | -$0.025 | 1 |
| Jun 2024 | $1.20M | $1.20M - $1.20M | -$1.20M | -$0.015 | 1 |
| Jun 2023 | $892.1K | $892.1K - $892.1K | -$892.1K | -$0.018 | 1 |
| Jun 2022 | $1.40M | $1.40M - $1.40M | -$1.40M | -$0.018 | 1 |
| Jun 2021 | $2.60M | $2.60M - $2.60M | -$2.60M | -$0.015 | 1 |